Back
Arcturus Therapeutics Holdings Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
ARCT
Arcturus Therapeutics Holdings
Last Price:
16.94
Seasonality Move:
11.22%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Arcturus Therapeutics Holdings Stock Forecast
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 30.4% based on the past 11 years of stock performance.
- Arcturus Therapeutics Holdings has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
-
Is Arcturus Therapeutics Holdings Stock Undervalued?
The current Arcturus Therapeutics Holdings [ARCT] share price is $16.93. The Score for ARCT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal. - ARCT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings Stock Go Up Next Year?
- Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 30.4% based on the past 11 years of stock performance.
Arcturus Therapeutics Holdings Stock Rating
Sell
27
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings overpriced?
- Arcturus Therapeutics Holdings has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
Arcturus Therapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
45.00
52-Week Low:
14.93
Prediction Charts
Market Cap:
458.59M
Price in USD:
16.93
Volume:
254.71K
Beta:
2.54
Technical Analysis
SMA50:
20.09
SMA100:
20.71
SMA200:
26.44
52-Wk Change:
-29.19%
Stock Predictions
-
Is Arcturus Therapeutics Holdings stock public?
Yes, Arcturus Therapeutics Holdings is a publicly traded company. -
What is the Arcturus Therapeutics Holdings stock quote today?
The Arcturus Therapeutics Holdings stock price is 16.93 USD today. -
How to buy Arcturus Therapeutics Holdings stock online?
You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-7 | 18.87 | 18.75 | 19.28 | 18.54 |
| Nov-8 | 19.50 | 19.63 | 19.93 | 18.81 |
| Nov-11 | 20.25 | 20.33 | 21.61 | 20.12 |
| Nov-12 | 20.00 | 19.56 | 20.07 | 18.90 |
| Nov-13 | 19.43 | 19.18 | 20.01 | 19.13 |
| Nov-14 | 19.20 | 18.34 | 19.57 | 18.30 |
| Nov-15 | 18.00 | 16.02 | 18.00 | 14.93 |
| Nov-18 | 16.08 | 16.27 | 17.37 | 15.71 |
| Nov-19 | 16.27 | 18.06 | 18.09 | 16.18 |
| Nov-20 | 17.94 | 16.17 | 17.94 | 15.94 |
| Nov-21 | 16.22 | 17.07 | 17.30 | 15.50 |
| Nov-22 | 17.01 | 16.91 | 17.50 | 16.20 |
| Nov-25 | 17.41 | 17.58 | 18.31 | 17.32 |
| Nov-26 | 17.53 | 16.93 | 17.83 | 16.83 |
Arcturus Therapeutics Holdings Earnings
Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings Forecast Revenue Growth
Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.91 per share.
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.